Japanese gastric cancer treatment guidelines 2014 (ver. 4).
about
Clinical utility of the platelet-lymphocyte ratio as a predictor of postoperative complications after radical gastrectomy for clinical T2-4 gastric cancerExploring the Evidence of Expanded Criteria for Endoscopic Resection of Early Gastric Cancers.Satisfactory surgical outcome of T2 gastric cancer after modified D2 lymphadenectomy.Postoperative chemotherapy with S-1 plus oxaliplatin versus S-1 alone in locally advanced gastric cancer (RESCUE-GC study): a protocol for a phase III randomized controlled trial.The optimal extent of gastrectomy for middle-third gastric cancer: distal subtotal gastrectomy is superior to total gastrectomy in short-term effect without sacrificing long-term survival.Five-year Survival Associated with Stage I Gastric Cancer after Resection of Early Recurrence at Nodal Station No. 14v: a Case Report.Feasibility and diagnostic performance of dual-tracer-guided sentinel lymph node biopsy in cT1-2N0M0 gastric cancer: a systematic review and meta-analysis of diagnostic studiesClinicopathological features of alpha-fetoprotein producing early gastric cancer with enteroblastic differentiation.Intra-Abdominal Complications after Curative Gastrectomies Worsen Prognoses of Patients with Stage II-III Gastric Cancer.Endoscopic Ultrasound-Guided Drainage of Intra-Abdominal Abscess after Gastric Perforation in a Patient Receiving Ramucirumab and Paclitaxel for Advanced Gastric Cancer.A Case of Advanced Gastric Cancer with Para-Aortic Lymph Node Metastasis from Co-Occurring Prostate CancerSignificance of CD47 expression in gastric cancer.Left Gastric Artery Lymph Nodes Should Be Included in D1 Lymph Node Dissection in Gastric Cancer.Value and impact factors of multidetector computed tomography in diagnosis of preoperative lymph node metastasis in gastric cancer: A PRISMA-compliant systematic review and meta-analysis.Postoperative follow-up programs improve survival in curatively resected gastric and junctional cancer patients: a propensity score matched analysis.Results of a nationwide questionnaire-based survey on nutrition management following gastric cancer resection in Japan.Role of hepatectomy in gastric cancer with multiple liver-limited metastases.Second-line chemotherapy for patients with advanced gastric cancer.A prospective multi-institutional validity study to evaluate the accuracy of clinical diagnosis of pathological stage III gastric cancer (JCOG1302A).Different time trend and management of esophagogastric junction adenocarcinoma in three Asian countries.Patterns of Initial Recurrence in Gastric Adenocarcinoma in the Era of Preoperative Therapy.Molecular classification of gastric cancer.Multi-institutional prospective feasibility study to explore tolerability and efficacy of oral nutritional supplements for patients with gastric cancer undergoing gastrectomy (CCOG1301).Survival after failure of first-line chemotherapy in advanced gastric cancer patients: differences between Japan and the rest of the world.Status and Prospects of Robotic Gastrectomy for Gastric Cancer: Our Experience and a Review of the LiteratureModeling preoperative risk factors for potentially lethal morbidities using a nationwide Japanese web-based database of patients undergoing distal gastrectomy for gastric cancer.Validation of the American Joint Commission on Cancer (8th edition) changes for patients with stage III gastric cancer: survival analysis of a large series from a Specialized Eastern Center.Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection.Surveillance strategy according to age after endoscopic resection of early gastric cancer.Long-term oncological outcomes of submucosal manipulation during non-curative endoscopic submucosal dissection for submucosal invasive gastric cancer: a multicenter retrospective study in Japan.The influence of neoadjuvant chemotherapy on gastric cancer patients' postoperative infectious complications: What is the negative role played by the intestinal barrier dysfunction?Early detection of nonperitoneal recurrence may contribute to survival benefit after curative gastrectomy for gastric cancer.Postoperative bleeding in patients on antithrombotic therapy after gastric endoscopic submucosal dissection.Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy.Metastatic adnexal cancer in a manRobotic versus laparoscopic Gastrectomy for gastric cancer: a systematic review and updated meta-analysisSuccessful conversion surgery for gastric cancer with multiple liver metastases treated after S-1 plus cisplatin combination chemotherapy: a case reportMetachronous solitary splenic metastasis arising from early gastric cancer: a case report and literature review.Comparisons of short-term and survival outcomes of laparoscopy-assisted versus open total gastrectomy for gastric cancer patients.Magnifying Endoscopy with Blue Laser Imaging Improves the Microstructure Visualization in Early Gastric Cancer: Comparison of Magnifying Endoscopy with Narrow-Band Imaging.
P2860
Q33572643-1EBB7E01-14E8-487A-B345-64CEF09C350FQ33584002-BD0CC656-8B4E-4A3E-8986-73028C7F6DC4Q33649932-BC9AA2C4-302E-42E9-8CCB-2DEF42D6203FQ33649965-4BDA3129-34A5-40B7-8236-389F42BBB12FQ33706928-5A764E93-F06D-406F-845A-2154C9AE93FEQ33849318-A557DB01-7D47-410F-A227-77F5CEF18A6FQ36373547-7FC22253-08A0-4296-B691-5DA4D7B0488CQ37284508-3FFC5E9C-DF2E-4304-9EF9-1DB1D55BB454Q37310182-A6019D58-6A75-4811-B70E-BD2C23073845Q37634902-4BE36CFA-9C33-4F9C-90BB-49F08944EDB3Q37717205-370A4FFB-926E-43D0-9043-B2CA96C888D5Q38374258-D2F1A59F-E836-4147-9E57-9071660369F6Q38618861-8DA4F0C3-FA73-4FA8-ACB2-77C4C4B98CCCQ38620309-FECED6BE-7A14-470A-93CF-037447DFAD37Q38663129-9F83538C-BEB1-4621-8097-7AC2DE221EB7Q38732950-2DDBDFF7-BBA6-404B-96FA-6B159EDBFAA6Q38747280-E3297356-3120-4047-A460-203ABB3923B3Q38750633-804FC533-6310-4918-ACDE-4C998AC95F0EQ38757945-BF56F877-80AA-4285-86B8-31362F6510B4Q38829135-07D63612-076B-43A0-A394-6058282D37DDQ38884728-20624A15-CEAF-41AD-BC7E-7B2D20A1CE0FQ39101373-45E6326C-70B0-4459-B320-C5E88FBFB99BQ39155159-06B61DBF-2E77-4161-BE71-7293A227B06FQ39234296-DAC4166D-368A-43FA-8191-8A5216B3C28BQ39381671-BBBCB7A5-7F96-493F-9687-C2DEACF61CA5Q39461484-30A09778-949C-44A5-89AC-2A3306B65C58Q40039318-9322449C-C2AE-481A-949D-FDC4E990F82DQ40097546-5A8FBB6D-2463-463D-B0EB-E0B0B8ACFB10Q40124214-CC1A061B-6981-404D-8E14-F62E5BB146D8Q40150184-8827DD21-B73B-4161-9CE6-184AE8DFDBC3Q40359839-63080E5B-BA33-4C5C-9715-EF5A95FD73FBQ40517538-3161CF70-BC5F-4B3D-A923-23EB2B93B426Q41426404-3AE5A3EF-9003-425E-8F2E-74D1D30E4634Q41431591-0A736400-0B7C-4BD1-8DD8-F5905B30FF7FQ41486414-A0CED0B0-C660-4F42-B04F-2F3BCDBE7931Q41520182-5BD2B031-EF7D-4CDF-A2F4-F72E193CA206Q41546984-8ACB03B4-6C2F-4C95-A335-7B1E653BCD0FQ41557871-FED65AF8-9EEF-40F4-858E-E3ACF806DDD5Q41592720-7A0FF816-57CA-4BB5-A97D-1C2AC30D0C0FQ41692173-A6AAFC4A-6448-47C0-B116-88C6A34F1D29
P2860
Japanese gastric cancer treatment guidelines 2014 (ver. 4).
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Japanese gastric cancer treatment guidelines 2014 (ver. 4).
@en
Japanese gastric cancer treatment guidelines 2014
@nl
type
label
Japanese gastric cancer treatment guidelines 2014 (ver. 4).
@en
Japanese gastric cancer treatment guidelines 2014
@nl
prefLabel
Japanese gastric cancer treatment guidelines 2014 (ver. 4).
@en
Japanese gastric cancer treatment guidelines 2014
@nl
P2860
P1433
P1476
Japanese gastric cancer treatment guidelines 2014 (ver. 4).
@en
P2093
Japanese Gastric Cancer Association
P2860
P2888
P356
10.1007/S10120-016-0622-4
P577
2016-06-24T00:00:00Z